Varda Shalev - 15 Jul 2021 Form 4 Insider Report for PLURISTEM THERAPEUTICS INC (PLUR)

Reporting relationship: Director
Issuer ticker: PLUR
Reported as of: 15 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jul 2021, 16:24:45 UTC
Next SEC filing: 05 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ Varda Shalev

Key filing fact

Varda Shalev filed Form 4 for PLURISTEM THERAPEUTICS INC (PLUR) on 26 Jul 2021.

Key facts

This page summarizes Varda Shalev's Form 4 filing for PLURISTEM THERAPEUTICS INC (PLUR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Jul 2021, 16:24.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLUR transaction

Restricted Stock Units

Award

Transaction value: $0
Shares: +20,000
Change %
Price: $0.000000
Shares after: 20,000
Date: 15 Jul 2021
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal instalments every 3 months thereafter.